Document:

Exhibit 10.63

 

AMENDMENT
TO WARRANT

 

This
agreement (the “Amendment Agreement”) is made and entered into as of November 2, 2017 by and between Omagine, Inc.,
a Delaware corporation (the “Corporation”) and Jeffrey A. Grossman (the “Holder”). This Amendment Agreement
is an amendment to that certain Warrant between the Corporation and the Holder dated April 13, 2017 (the “Warrant”).
The Warrant is incorporated into this Amendment Agreement by reference thereto. Capitalized terms used in this Amendment Agreement
and not otherwise defined herein shall have the meaning given to them in the Warrant.

 

Pursuant
to Section 11 of the Warrant, the Corporation and the Holder hereby consent to the following amendments to the Warrant:

 

		1.	Section
                                         1.5 of the Warrant is hereby replaced in its entirety to read as follows:

 

“Exercise
Price” means, per share of Common Stock, fifty cents ($0.50).

 

		2.	Section
                                         1.6 of the Warrant is hereby replaced in its entirety to read as follows:

 

“Expiration
Date” means June 30, 2018.

 

		3.	There
                                         is a typographical error in Section 2 of the Warrant where two sub-sections are numbered
                                         as Sections 2.2. The second such sub-Section is hereby changed to Section 2.3 and the
                                         wording of such Section 2.3 along with the wording of Sub-Sections 2.1 and 2.2 are not
                                         amended in any way and remain as originally drafted in the Warrant. The opening paragraph
                                         of Section 2 of the Warrant is hereby replaced in its entirety to read as follows:

 

Exercise
of Warrant. At any time before the Expiration Date, the Holder may exercise the purchase rights represented by this Warrant,
in whole or in part, by surrendering this Warrant (with a duly executed subscription certificate substantially in the form attached
hereto) at the Corporation’s principal office in New York City, New York, and by either: (i) paying the Exercise Price in
cash to the Corporation, or (ii) electing to pay the Exercise Price via the cashless exercise feature of this Warrant as follows:
by delivering an Exercise Notice and in lieu of making payment for the aggregate Warrant exercise price in cash or wire transfer,
elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according to the
following formula (the “Cashless Exercise”):

 

Net
Number = (A x B) – (A x C)

B

 

For
purposes of the foregoing formula:

 

	A
    =	the
    number of shares of Common Stock with respect to which the Warrant is being exercised.
	 	 
	B
    =	the
    closing price of the Common Stock on the Trading Day immediately preceding the relevant exercise date of the Warrant.
	 	 
	C
    = 	the
    Exercise Price.

 

Neither
the Warrant nor this Amendment Agreement may be altered, amended or modified in any way except by a written instrument signed
by the Corporation and the Holder.

 

IN
WITNESS WHEREOF, the Corporation and the Holder have executed this Amendment Agreement as of the date first above written.

 

	Omagine,
    Inc.	 	Holder
	 	 	 	 	 
	By:	/s/  Charles
    P. Kuczynski	 	By:	/s/  Jeffrey
    A. Grossman
	 	Charles
    P. Kuczynski	 	 	Jeffrey
    A. Grossman
	 	Vice
    President and SecretaryExhibit 10.64

 

AMENDMENT TO CONVERTIBLE PROMISSORY NOTE

 

This agreement (the “Amendment Agreement”)
is made and entered into as of November 2, 2017 by and between Omagine, Inc., a Delaware corporation (the “Company”)
and Jeffrey A. Grossman (the “Lender”). This Amendment Agreement is an amendment to that certain Convertible Promissory
Note between the Company and the Lender dated July 3, 2017 (the “Note”). The Note is incorporated into this Amendment
Agreement by reference thereto. Capitalized terms used in this Amendment Agreement and not otherwise defined herein shall have
the meaning given to them in the Note.

 

Pursuant to Section 8(c) of the Note, the
Company and the Lender hereby consent to the following amendments to the Note:

 

		(1)	Section 2 (a) (i) of the Note is hereby replaced in its entirety to read as follows:

 

Optional Conversion.
The Lender shall have the right, at his option, to convert all or any portion of the outstanding principal amount of this
Note into fully-paid and non-assessable shares of the Company’s $0.001 par value per share common stock, (“Common
Stock”), at the conversion price of ten cents ($0.10) per share (the “Conversion Price”). The $0.10 Conversion
Price shall be further modified to the lower of (a) five cents ($0.05) on December 15, 2017 if the separate $146,000 Convertible
Promissory Note between the Lender and the Company dated November 2, 2017 is not paid in full on or before December 15, 2017,
or (b) the lowest price at which any party purchases Common Stock or equivalents directly from the Company, or the lowest stated
or modified conversion price in any Note issued by the Company, or the lowest stated or modified exercise price in any option
or warrant to purchase Common Stock issued by the Company (the foregoing a or b being the “Modified Conversion Price”).
The Modified Conversion Price shall remain in full force and effect until the Note is fully paid. Upon conversion of the Note,
subject to the provisions of Section 2(c) below, the Lender shall be entitled to that number of shares of Common Stock determined
by dividing (x) the then outstanding principal amount of this Note by (y) the Conversion Price or the Modified Conversion Price
(as the case may be) provided, however, that in no event shall the Lender be entitled to convert any portion of
this Note in excess of that portion of this Note upon conversion of which the sum of (1) the number of shares of Common Stock
beneficially owned by the Lender and his affiliates, if any, and (2) the number of shares of Common Stock issuable upon the conversion
of the portion of this Note with respect to which the determination of this proviso is being made, would result in beneficial
ownership by the Lender and his affiliates, if any, of more than 4.99% of the outstanding shares of Common Stock (the “Limitation”)
without the written permission of the Company, which permission the Company may or may not grant at its sole discretion. For purposes
of the proviso in the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d)
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulations 13D-G thereunder. The number
of shares of Common Stock to be issued upon conversion of this Note shall be determined by dividing the Conversion Amount by the
applicable Conversion Price then in effect on the date specified in the Conversion Notice, (as defined below).

 

    	 		 

     

    

 

In order to exercise this optional conversion privilege, the Lender shall surrender this Note to the Company
during usual business hours at the Company’s principal executive office, accompanied by written notice (a “Conversion
Notice”) in form satisfactory to the Company that the Lender elects to convert all or any portion of the principal amount
then outstanding of this Note. Such notice shall also state the amount to be converted and the name or names (with address) in
which the certificate or certificates for shares of Common Stock that shall be issuable on such conversion shall be issued. If
less than the entire principal amount then outstanding is converted the Company shall cancel this Note and reissue an identical
note in the amount of the remaining principal amount outstanding after any such conversion.

 

		(2)	Section 2 (b) (ii) of the Note is hereby replaced in its entirety to read as follows:

 

Immediately upon surrender of this Note
for conversion of all or any portion of the then outstanding principal amount of this Note as herein provided, this Note shall
no longer be deemed to be outstanding with respect to that portion of this Note to be converted and all rights with respect to
this Note or such portion of this Note (as the case may be) shall immediately cease and terminate on the conversion date, except
only the right of the Lender to receive shares of Common Stock in exchange therefor. This Note, when so surrendered for conversion,
shall be cancelled. Immediately upon surrender of this Note for conversion of less than the full principal amount of this this
Note then outstanding, the Company shall cancel the original Note and reissue a new note to the Lender for the remaining balance
of the Note, and this Note shall no longer be deemed to be outstanding and all rights with respect to this Note shall immediately
cease and terminate on the conversion date, except only the right of the Lender to receive (i) shares of Common Stock in exchange
therefor and (ii) the new note for the remaining principal balance of the Note. The new note will have the same terms of the original
Note as amended hereby.

 

		(3)	Section 4 of the Note is hereby replaced
                                         in its entirety to read as follows: Prepayment of Principal. The principal
                                         indebtedness represented by this Note may be prepaid at any time in whole or in part,
                                         with the consent of Lender, subject to the right of the Lender to convert the outstanding
                                         principal in accordance with Section 2 hereof.

 

		(4)	Section 6 of the Note is hereby amended to add new Item (e) as follows:

 

		(e)	while this Note is outstanding in whole or in part, the Company agrees to not issue any new common
stock or equivalents, including new stock options, warrants or SARs, to Company management or directors until the Company’s
majority owned subsidiary, Omagine LLC, a limited liability company in the Sultanate of Oman (“LLC”), has received
a minimum investment of fifteen million U.S. dollars ($15,000,000) (except for the payment that the Company is required to make
to its three independent directors in restricted common shares on an annual basis with the next restricted common stock payment
due them in January 2018). Similarly, the Company may not extend or reprice existing stock options, warrants, SARs held by Company
management or directors (except for the Strategic Options, Strategic Warrants and Strategic SARs which may be extended but not
repriced). Further, while this Note is outstanding in whole or in part, the Company may not allow for the conversion of any accrued
salary or accrued independent director fees into the Company’s common stock until the $15,000,000 LLC investment milestone
has been achieved. For clarity, this Section 6(e) is designed to prohibit Company management from receiving any new common stock
or derivatives, or repricing of any existing derivatives until LLC receives the minimum $15,000,000 investment, but does not preclude
the Company from issuing stock to other non-management persons or entities in its normal course of business.

 

Neither the Note nor this Amendment Agreement
may be altered, amended or modified in any way except by a written instrument signed by the Company and the Lender.

 

    	 	2	 

     

    

 

IN WITNESS WHEREOF, the Company and the
Lender have executed this Amendment Agreement as of the date first above written.

 

	Omagine, Inc.	 	Holder
	 	 	 	 	 
	By:	/s/ Charles P. Kuczynski	 	By:	/s/ Jeffrey A. Grossman
	 	Charles P. Kuczynski	 	 	Jeffrey A. Grossman
	 	Vice President and Secretary	 	 	 

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}]]